Rendered visual concept — not inventory photography. Label text in imagery is decorative.
Metabolic
Semaglutide
Currently unavailable
GLP-1 receptor agonist (acylated GLP-1 analogue)
Strength
5 mg
Vial count
Unspecified
Strength of evidence
Approved medicine (specific indications)
Research summary
Long-acting GLP-1 analogue studied extensively in large randomized trials of glycaemic control and body-weight outcomes.
Regulatory status
Approved in Canada only as specific branded prescription products. Unbranded research material is not an approved drug.
No certificate of analysis or purity figure is shown because none has been verified for this demo. No dosing information is provided.
Information only. Purchases and payments are disabled.
Regulatory notice (Canada): Labelling a product “for research use only” does not make it legal to sell unapproved injectable peptides. In Canada, drugs for human use require Health Canada authorization. This site is a non-transactional design demo: nothing is for sale, and nothing here is medical advice or dosing guidance.